{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:09:48Z","timestamp":1772168988433,"version":"3.50.1"},"reference-count":11,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005027","name":"Belgisch Ontwikkelingsagentschap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns3:p>\n                    In the African meningitis belt (region from Senegal to Ethiopia), there are around 30,000 reported cases of meningococcal disease per year. The main aetiological agent is\n                    <ns3:italic>Neisseria meningitidis<\/ns3:italic>\n                    of serogroup A. Since 2010, vaccination efforts have increased and\u00a0hundreds of millions of people have been vaccinated. There are indications that the epidemiology of meningococcal disease is changing. This is the protocol of a scoping review, the objective of which is to describe the extent and nature of the research evidence about the impact of vaccination on meningitis frequency. Primary studies and reviews are eligible for inclusion in the review if they assess the impact of interventions that include\n                    <ns3:italic>N. meningitidis<\/ns3:italic>\n                    vaccination in countries of the African meningitis belt, report meningitis frequencies, and include an element of comparison. The sources of records are electronic databases (MEDLINE, Cochrane register of clinical trials, African Index Medicus, and\n                    <ns3:ext-link xmlns:ns4=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" ns4:href=\"http:\/\/clinicaltrials.gov\">clinicaltrials.gov<\/ns3:ext-link>\n                    ), surveillance reports at country level,\u00a0online resources of large stakeholders involved in vaccination, reference lists of included records, and experts in the field. The search strategy is based on the combination of the condition of interest, the intervention, and the geographical region. The findings of this review will be presented using figures, tables, and thematic narrative synthesis. This review will not produce a pooled estimate of what the impact of vaccination is, but will give insight in how the authors of the included records assessed the impact.\n                  <\/ns3:p>","DOI":"10.12688\/f1000research.21164.1","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T07:25:09Z","timestamp":1573802709000},"page":"1922","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of interventions including vaccination against Neisseria meningitidis on the frequency of meningitis in the African meningitis belt: a scoping review protocol"],"prefix":"10.12688","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6267-4954","authenticated-orcid":false,"given":"Niurka","family":"Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greissi","family":"Justiniani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisset","family":"Urquiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Eugenia","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-8429","authenticated-orcid":false,"given":"Chukwuemeka","family":"Onwuchekwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1153-4078","authenticated-orcid":false,"given":"Kristien","family":"Verdonck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermias","family":"Diro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-6361","authenticated-orcid":false,"given":"Nivaldo","family":"Linares-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"ref-1","first-page":"318-332","article-title":"Oxford textbook of medicine: infection","author":"P Brandtzaeg","year":"2012"},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"1107-1115","DOI":"10.1080\/21645515.2017.1412020","article-title":"Vaccine prevention of meningococcal disease in Africa: major advances, remaining challenges.","volume":"14","author":"M Mustapha","year":"2018","journal-title":"Hum Vaccin Immunother."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"1-6","DOI":"10.1080\/20477724.2016.1274068","article-title":"Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.","volume":"111","author":"I Mohammed","year":"2017","journal-title":"Pathog Glob Health."},{"key":"ref-4","article-title":"Meningococcal meningitis key facts"},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1-11","DOI":"10.1016\/j.jinf.2017.04.007","article-title":"Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative.","volume":"75","author":"R Borrow","year":"2017","journal-title":"J Infect."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"91-108","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: an analysis of 14 review types and associated methodologies.","volume":"26","author":"M Grant","year":"2009","journal-title":"Health Info Libr J."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"355-368","DOI":"10.1108\/07378830610692127","article-title":"Clear and present questions: Formulating questions for evidence based practice.","volume":"24","author":"A Booth","year":"2006","journal-title":"Library Hi Tech."},{"key":"ref-8","article-title":"SupplementaryInformation_Eligibility_DataExtraction.","author":"K Verdonck","year":"2019","journal-title":"figshare."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.","volume":"350","author":"L Shamseer","year":"2015","journal-title":"BMJ."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"467-473","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.","volume":"169","author":"A Tricco","year":"2018","journal-title":"Ann Intern Med."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/8-1922\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-1922\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-1922\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T08:05:10Z","timestamp":1647245110000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/8-1922\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":11,"URL":"https:\/\/doi.org\/10.12688\/f1000research.21164.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.23296.r63667","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.23296.r121240","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.23296.r63667","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.23296.r121240","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/8-1922\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.23296.r63667, James M. Stuart, Clare French, Population Heath Sciences, Bristol Medical School, University of Bristol, Bristol, UK, 03 Jun 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-1922\/v1#referee-response-63667","order":0,"name":"referee-response-63667","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.23296.r121240, Charlene M Kahler, Marshall Centre for Infectious Disease Research and Training, School of Biomedical Sciences, University of Western Australia, Crawley, Western Australia, 6009, Australia, 14 Mar 2022, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-1922\/v1#referee-response-121240","order":1,"name":"referee-response-121240","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The review protocol was developed during a workshop on evidence synthesis in September 2019 in Cuba. The workshop was organised by the Instituto Pedro Kour\u00ed (Cuba), the Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia (Peru), and the Institute of Tropical Medicine of Antwerp (Belgium), and received partial support from the Belgian Development Cooperation through the Fourth Framework Agreement (FA4). The authors declared that no other grants were involved in supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}